Stearoyl-CoA desaturase (SCD) inhibitor, GSK1940029, Purity ≥98%

Synonym: 1150701-66-8; SCD inhibitor 1; GSK 1940029; GSK-1940029; 1-[(3,4-Dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide; Stearoyl-CoA desaturase (SCD) inhibitor

CAS Number: 1150701-66-8
Compound CID: 42603008

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

GSK1940029 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting stearoyl-CoA desaturase (SCD). The molecular weight of the compound is 391.25, and its molecular formula is C₁₈H₁₆Cl₂N₄O₂.

Molecular Weight

391.25

Molecular Formula

C₁₈H₁₆Cl₂N₄O₂

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

GSK1940029 can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes, helping to lower blood sugar levels by prolonging the action of incretin hormones.